SECTOR ANALYSIS

Immunology Oncology Biotech Companies

Grades, scores, and FDA catalyst signals for Immunology Oncology stocks tracked by BiotechSign

← Full ScreenerFDA CalendarAll Sectors
Companies
45
Avg Score
44
Top Grade
C
Immunology Oncology Companies45 tracked
TickerCompanyScoreGradeSectorSignals
NKTRNektar Therapeutics64CImmunology
BGNEBeiGene Ltd63COncology
DCPHDeciphera Pharmaceuticals63COncology
TOIThe Oncology Institute, Inc.61COncology
KURAKura Oncology, Inc.60COncology
SNDXSyndax Pharmaceuticals58COncology
NUVBNuvation Bio57COncology
CABACabaletta Bio57CImmunology
NUVLNuvalent Inc57COncology
RIGLRigel Pharmaceuticals56CImmunology
CELCCelcuity Inc56COncology
TGTXTG Therapeutics55COncology
GERNGeron Corporation54COncology
EXELExelixis Inc54COncology
ALXOALX Oncology53COncology
MGNXMacroGenics Inc53COncology
BPMCBlueprint Medicines53COncology
INCYIncyte Corporation53COncology
SNYSanofi SA52CImmunology
ABBVAbbVie Inc52CImmunology
BMYBristol-Myers Squibb51COncology
LBPHLongboard Pharmaceuticals48DOncology
ITOSiTeos Therapeutics45DOncology
ERASErasca Inc40DOncology
ZNTLZentalis Pharmaceuticals40DOncology
ONCYOncolytics Biotech, Inc.40DOncology
KPTIKaryopharm Therapeutics40DOncology
CGONCG Oncology, Inc.38DOncology
CRDFCardiff Oncology, Inc.38DOncology
ALPNAlpine Immune Sciences37DImmunology
CATXPerspective Therapeutics36DOncology
CRVSCorvus Pharmaceuticals34FOncology
AIMAIM ImmunoTech Inc.34FImmunology
BCABBioAtla Inc34FOncology
CRBPCorbus Pharmaceuticals31FOncology
LTRNLantern Pharma28FOncology
CDTXCidara Therapeutics27FOncology
PYXSPyxis Oncology, Inc.26FOncology
APGEApogee Therapeutics25FImmunology
CGEMCullinan Oncology25FOncology
IMNMImmunome, Inc.25FImmunology
FUSNFusion Pharmaceuticals24FOncology
ESLAEstrella Immunopharma, Inc.22FImmunology
ANABAnaptysBio Inc22FImmunology
LEGNLegend Biotech22FOncology
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSign grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.